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Summary  
The objective of this study was to assess the effect of mechanical load on articular cartilage after in vitro corticosteroid 
exposure. Canine humeral cartilage was equilibrated for 4 days in defined medium with a serum substitute, then exposed 
to methylprednisolone sodium succinate for 20 h at 0, 0.01 or 1.0 mg/ml. After a drug-free recovery period, the explants 
were subjected to 0, 1 or 10 mega pascals (MPa) for 1 out every 5 s for 20 min, then incubated with [35S]-sulfate and 
[3H]-leucine for 4 h to measure proteoglycan and protein synthesis, respectively. When the loading occurred 22 h after 
drug exposure, proteoglycan synthesis was inhibited and protein synthesis was unaffected by the drug. Both were 
stimulated by load, relative to controls. When the loading was delayed until 142 h after drug exposure, there was no 
biosynthetic response to load whether or not the explant had been exposed to the drug. Proteoglycan and protein 
synthesis 142 h after 0 or 0.01 mg/ml were unchanged or slightly higher than at 22 h, in explants which did not receive 
load. In contrast, biosynthesis were strongly inhibited 142 h after 1.0 mg/ml, and there was a 40% loss of proteoglycan 
content, relative to 22 h controls. If explants receiving 1.0 mg/ml also received heavy (10 h/[Pa) loads 142 h later, there 
was a 17% reduction in total dry content suggesting severe matrix damage. These in vitro results suggest that articular 
load can help maintain ormal cartilage metabolism after corticosteroid exposure, but also suggest that heavy loading 
after a sub-clinical dose can cause a marked loss of matrix solids. 
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Introduct ion 
CORTICOSTEROIDS are  used to t reat  a var iety of 
arthr i t ic  condit ions in human medicine. Intra- 
ar t icu lar  cort icosteroid in ject ion is also used 
commonly in horses to reduce synovit is due to 
distal jo int  t rauma and/or  an osteochondra l  chip 
f racture [1, 2]. Cort icosteroids act direct ly on 
nuclear  steroid receptors in the synovial  cells to 
reduce in f lammatory responses to jo int  in jury 
[3, 4]. In addit ion to providing symptomatic  rel ief  
of jo int pain and swelling, modern cort icosteroids 
seem to inhibit  the synthesis of proteolyt ic  
enzymes like stromelysin and col lagenase [5-7]. 
However, thei r  side-effects on the art icu lar  carti- 
lage cells may accelerate jo int  degradat ion [8-11]. 
Of par t icu lar  concern, cart i lage proteoglycan (PG) 
sulfat ion is in ter rupted by cl inical doses [9], 
leading to a net loss of cart i lage matr ix  solids 
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[1, 12, 13] and possibly reducing the joint's abi l i ty 
to support  b iomechanica l  loads [14]. 
It is not uncommon for human or equine pat ients 
to resume strenuous physical  t ra in ing within a few 
days after cort icosteroid in ject ion therapy. This 
pract ice is controvers ia l  because the drug's 
analgesic effect may mask insidious effects on bony 
and soft tissues. St renuous exercise after cort icos- 
teroid in ject ion has been reported to accelerate 
jo int  degenerat ion i laboratory rats [15]. Cl inical  
studies of ponies and horses also suggest that  
unrestr ic ted activity after in ject ion therapy can 
cause premature jo int  degenerat ion [13, 14, 16], but 
some of these data are open to in terpretat ion  
because of the presence of a pre-existing jo int  
abnormality. When horses with normal  jo ints 
received cort icosteroid t reatment  followed by 
paddock or treadmil l  exercise, there was no clear 
detr imental  effect Of exercise [18, 19]. Running 
alone has been reported to have positive effects on 
heal thy cart i lage [20], so moderate exercise may 
even be beneficial  after cort icosteroid t reatment.  
These ideas could be tested exper imental ly  at the 
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who~e animal level, but it might be difficult to 
justify a comprehensive study involving a large 
athletic species like the horse or the dog or man. 
Tl~e objective of this study was to assess the 
combined effects of methylprednisolone exposure 
and later mechanical loading on PG and protein 
synthesis and retention in normal canine cartilage, 
under well-regulated in vitro conditions. 
Mater ia l s  and  Methods  
OVERVIEW 
Canine cartilage explants in defined culture 
were exposed to methylprednisolone sodium ~, 
succinate, and later subjected to a brief period 
of pulsatile loading at one of two time points 
[Fig. l(a)]. 
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EXPLANT CULTURE 
Normal humeral head cartilage was collected 
from the shoulders of two skeletally-mature 
Labrador Retriever dogs aged 10 and 12 months old. 
The animals were healthy and had no clinical signs 
or history of articular joint disease. All four 
shoulder joints were opened within 2h  of eu- 
thanasia and were macroscopically normal at 
necropsy. The joint surfaces were kept moist with 
Gey's balanced salt solution (Gibco Laboratories, 
Grand Island, NY, USA) plus 20 units/ml penicillin 
and 20 #g/ml streptomycin (also Gibco), and full 
thickness disks of articular cartilage were excised 
from the loadbearing surfaces of the humeral head 
using a 4 mm diameter dermal punch and a #12 
scalpel blade. 
Each cartilage disk was rinsed in Gey's plus 
antibiotics, and transferred to a tissue culture well 
containing Ham's F-12 medium (also Gibco) 
supplemented with additions including a serum 
substitute (ITS+, Collaborative Biomedical Prod- 
ucts, Bedford, MD, USA), ascorbate, and calcium 
[2]. This medium is optimized for glycosamino- 
glycan (GAG) synthesis and helps maintain PG 
with a large hydrodynamic volume [22]. The 
cartilage disks were incubated for 4 days in this 
medium at 37°C in 5% CO2 to allow them to 
recuperate from the trauma of harvesting. 
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FIG. 1 (a) Timeline used to study the effects of 
corticosteroid exposure and subsequent loading. The 
explant's wet weight at several time points was compared 
to the reference level at 6 h. The drug treatment and 
loading protocols are described in detail in the Methods. 
Briefly, the drug exposure period began after 4 days in 
defined culture, and the loading session began 2 days 
(Load  A) or 7 days (Load B) later. Cortico-steroid ex- 
posure •; dual radiolabel exposure Bq ~t. (b) Schematic 
diagram of cartilage xplant mounted in loading chamber 
and bathed in defined medium. The cartilage disk C was 
secured on standing pin D by holddown ring B while solid 
indentor A subjected the cartilage disk to repeated 
impact loads, as described in the Methods. 
DRUG TREATMENT 
The explants were then exposed to methylpred- 
nisolone sodium succinate (Solu-Medrol, The 
Upjohn Co, Kalamazoo, MI, USA) for 20h 
beginning 100 h after harvest [Fig. l(a)] (this type 
of corticosteroid preparation is extremely soluble 
in water to speed clearance from the joint space 
after intra-articular injection). The drug was 
prepared according to the instructions enclosed 
with the manufacturer's 1 gm Act-O-Vial packag- 
ing. Appropriate quantities of the stock injectable 
solution were diluted in medium and the final drug 
concentration was 0, 0.01 or 1.0 mg/ml. At the end 
of the drug exposure period, each disk was 
transferred to a clean well containing fresh 
medium. Henceforth, we refer to 0.01 mg/ml as a 
low dose and 1.0 mg/ml as a high dose. 
To put the dose levels in perspective, a recent 
survey of equine veterinarians [12] found that the 
typical dose injected into an equine carpal joint 
was at least 10 mg/ml (assuming 2ml of 40 mg/ml 
suspension into 6 ml of synovial fluid). Thus, our 
high dose was about 10 times less concentrated 
than a clinical dose, and our low dose was about 
1000 times less concentrated than a clinical dose. 
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However, the constant high dose might exert 
metabolic effects comparable to the clinical dose 
because of the rapid clearance seen in vivo (~ 10 h 
half-life [23]). 
MECHANICAL LOADING 
The explants were subjected to pulsatile loading 
either 22 or 142h after drug exposure ended 
[Fig. l(a)]. Prior to loading, each cartilage disk was 
secured in a pre-warmed test chamber [Fig. l(b)] 
which was then mounted in a special load frame 
inside an incubator [24]. A 2 mm diameter solid 
indentor applied 0, 1, or 10 mega pascals (MPa) to 
the center of the disk for 1 out of every 5 s, for 
20 min. Since the fixtures did not restrict trans- 
verse expansion of the disk, the central core region 
would have experienced large compressive strains 
(up to 40% @ 10 MPa, [24]) during the pulsatile 
loading. However, the net volumetric strains stayed 
small (<1% @ 10MPa) because of the recovery 
period between each pulse. Henceforth, we refer to 
the 1MPa protocol as moderate load and the 
10 MPa protocol as heavy load. 
To put the load levels in perspective, the contact 
area which transmits a dog's weight through its 
shoulder is such that the 1 MPa load would be 
comparable to a gentle walk and the 10 MPa load to 
vigorous running. In more familiar units, a pressure 
of ~ 10 MPa would be realized if a person weighing 
150 pounds uddenly applied 10 times their weight o 
a contact area of one square inch. The period 
between drug exposure and load was chosen to 
mimic a recovery period between drug therapy and 
exercise, and the pulsatile waveform was chosen to 
approximate the loading cycle the cartilage might 
see in vivo. 
BIOSYNTHESIS 
Each disk was transferred to a tissue culture well 
within 2min after the loading session, and 
incubated in fresh medium containing Na~['~S]-SO4 
@ 10 uCi/ml and [3H]-leucine @ 20 uCi/ml (both 
from Amersham, Arlington Heights, IL, USA) 
for the next 4 h [Fig. l(a)]. T~ disk was then 
rinsed 4 × 15 min in 0.5 ml ice-~ld saline to remove 
free isotope, weighed, then frozen at -20°C to await 
later analysis. After thawing, each disk was divided 
physically into a core (high stress) and ring (low 
stress) using a 2 mm diameter dermal punch. Both 
pieces were digested in i mg/ml papain (Sigma, St. 
Louis, MO, USA), and aliquots in a scintillation 
cocktail (Ecosint, National Diagnostics, Atlanta, 
GA, USA) were counted using a Beckman LS6800 
scintillation counter. After correction for label 
spillover, [~5S] and [3H] content were calculated as 
measures of PG and protein synthesis 0-4 h after 
load, respectively. 
COMPOSITION 
Each explant was weighed at several time 
points. The explant was removed from its medium, 
gently blotted with sterile gauze, weighed on a 
Metler AT261 microbalance, then returned to 
defined culture. Weights were obtained at 3, 6, 9, 100, 
and either 142 and 148, or 262 and 268 h. The dry 
weights of the core and ring pieces were determined 
by our acetone drying method, as previously 
described [25]. The glycosaminoglycan weight of 
core and ring, as a measure of PG content, was 
determined using the dimethylmethylene blue 
dye-binding assay [26]. 
STATISTICAL ANALYSIS 
We used the cartilage of healthy dogs culled from 
a research colony because the joints of large 
athletic animals like the dog are more similar than 
those  of rodents to the joints of man. Ethical 
concerns aside, the economic and scientific value of 
these pure bred dogs mandated an efficient and 
meaningful experimental design. In our statistical 
analysis, the cartilage explant (N=108) was 
considered to be the smallest experimental unit. Six 
explants were randomly allocated to each treatment 
group in a complete block involving all possible 
combinations of (three levels of drug)x(three l vels 
of load) x (two levels of time), counting no drug and 
no load as levels. The statistical analysis of the 
biosynthetic and compositional data involved 
multiple analysis of variance (ANOVA) with donor, 
shoulder, dose, load, and recovery time as possible 
sources of variation. LSD values at P < 0.05 were 
used to determine where differences lay. 
Resu l ts  
EFFECT OF TIME 
The mean weight at 6h  was 8.808mg (S .D . :  
1.398~N= 108), and did not vary between 3, 6, and 9 h 
(P < 0.01). Using each explant's weight at 6 h as a 
reference, wet weight increased and then decreased 
over the next 11 days (Fig. 2). At 100 h, the mean 
weight was 2.5% above the 6 h level. At 142 h (22 h 
after drug exposure), the mean weight was 2.1% 
above the 6 h level and was as yet unaffected by the 
drug. At 262 h, themean weight was back to the 6 h 
level for no or low dose, and reduced 3.6% below the 
6h  level for high dose (P < 0.05). These small 
changes are significant because they reflect a paired 
comparison of weights taken at several time points. 
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FIG. 2. Cartilage xplant weight as a percentage ofweight 
after 6 h vs time in defined culture. Each explant was 
maintained in defined culture for up to 11 days, and its 
wet weight was determined at 6, 100, and 142 or 262 h, as 
described in the Methods. All weights were obtained 
prior to loading, but the explants were exposed to 
varying levels of methylprednisolone at 100-120h 
(3 x N= 36), also as described in the Methods. The values 
at 100, 142, and 262 h are mean +_ S.D. expressed as a 
percentage of explant weight at 6 hours. There were no 
differences between dose levels at 100 and 142 h, and all 
levels were pooled at these time points. The comparison 
between timepoints was by Student's t-test for a paired 
sample. Differences in explant weight are indicated by *, 
#, $ (P ~< 0.05). 
EFFECT OF  DRUG ALONE 
Corticosteroid exposure at 100-120h had no 
effect on total protein synthesis at 142-146h, 
relative to 3910 cpm/mg-wet uptake of [3H] in un- 
treated controls [Fig. 3(a)]. Protein synthesis was 
the same at 142-146 h vs 262-266 h for no or low 
dose explants, but the high dose had inhibited 
protein synthesis 56% by 262-266h. Drug ex- 
posure also inhibited PG synthesis at 142-146 h, 
reaching significance at the high dose level (-42%) 
relative to 104cpm/mg-wet uptake of [8~S] in 
untreated controls [Fig. 3(b)]. PG synthesis at 
262-266h was increased 39% after no dose, 
increased 89% after low dose, and decreased 49% 
after high dose, each relative to the 142-146 h level 
for the same dose. Differences between core and 
ring synthesis after drug exposure were not 
significant. 
EFFECT OF LOAD ALONE 
When moderate or heavy load was applied at 
142 h, it stimulated total protein synthesis in the 
core (but not in the ring), relative to controls 
[Fig. 4(a)]. This st imulation reached significance 
after heavy loading (+31%) but there was no effect 
if the loading was delayed until 262 h. PG synthesis 
was insensitive to load alone at both time points 
[Fig. 4(b)]; when all three load levels are pooled 
(that is 0, 1, 10 MPa), proteoglycan synthesis was 
slightly higher (34%) at 262-264h than at 
142-146 h. Most of the variabil ity in PG synthesis 
was due to dose or time effects, rather than to load. 
INTERACTION OF  DRUG,  LOAD AND T IME 
The effects of load on biosynthesis diminished 
with time in culture, but biosynthesis remained 
at or above control  levels as the time between 
low dose and load was increased from 22 h to 
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Protein synthesis or (b), proteoglycan 
synthesis in cartilage xplants versus in vitro corticos- 
teroid dose. Cartilage explants were exposed to 
methylprednisolone for 20 h starting at 100 h, and to 
[3H]-leucine and [3~S]-sulfate for 4 h starting at 142 ([]) or 
262 h ([3), as described in the Methods. The [SH] and [35S] 
content per wet weight of cartilage were measures of 
protein and proteoglycan synthesis about 1 or 6 days 
after drug exposure, respectively. In (a) and (b), the 
values are mean + S.D. (6 x N=6) normalized by the 
mean of 142 h controls. Differences in biosynthesis are 
indicated by *, %, $, § (P ~< 0.05). 
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FIG. 4. (a) Protein synthesis or (b) proteoglycan synthesis 
in core of cartilage explant vs load intensity. Cartilage 
disks in defined culture were subjected to repeated 
impact loading for 20 min ending at 142 (~) or 262 h (D), 
as described in the Methods. The disks were then 
incubated with [3H]-leucine and pS]-sulfate for 4 h. The 
[SH] and [35S] content per wet weight of the 2 mm core of 
the explant provided measures of protein and proteogly- 
can synthesis 0-4 h after loading, respectively. In (a) and 
(b) the values are mean + S.D. (6 x N= 6) normalized by 
the mean of 142 h controls. Differences in biosynthesis 
are indicated by *, t (P ~< 0.05). 
142 h (radiopulsed a t  142-146 h or 262-266 h after 
harvest).  At the ear l ie r  t ime point, protein 
synthesis was st imulated by load for each dose level 
[Fig. 5(a)]; when all three dose levels are pooled (0, 
0.01, 1.0 mg/ml), protein synthesis was st imulated 
24% by moderate load and 37% by heavy load. 
A l though PG synthesis was insensitive to load 
when the explant had not been exposed to the drug, 
heavy load st imulated core PG synthesis 42% or 
24% in explants exposed to low or high dose, 
respectively [Fig. 5(b)]. The mean biosynthet ic  
levels for N=6 untreated controls from each 
shoulder were within 5%. The power of our stat- 
istical test ing was too low to rule out small  
differences between shoulders, but this would not 
diminish the signif icance of the effects of drug, 
load, and t ime described above. 
The GAG content  of untreated controls,  as 
a percentage of 6 h wet weight, did not  vary 
with time, as measured at 148 h or 268 h [Fig. 6(a)]. 
The GAG content  of explants which had received 
heavy load at 262 h was s imi lar to controls, but  the 
GAG content  of explants which had received a 
h igh dose at 100-120 h was reduced 44%. As a 
percentage of 6 h wet weight, the total  dry content  
of explants which received heavy load at 262 h 
was s imi lar to that  of untreated controls  at 
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FIG. 5. (a) Protein synthesis or (b), proteoglycan synthesis 
in the core of cartilage explants versus eortieosteroid 
dose, for three levels of in vitro loading. The cartilage 
disks were exposed to methylprednisolone, and a day 
later subjected to impact loading, as described in the 
Methods. The [all] and [asS] content per wet weight 
respectively provided measures of protein and proteogly- 
can synthesis, 0-4h after loading and 22-26h after 
corticosteroid exposure (load at 142 h: no load []; 1 MPa 
[~; 10 MPa m). In (a) and Co) the values are mean + S.D. 
(9 x N=6) normalized by the mean of untreated 
controls. Differences in biosynthesis are indicated by *, 
¢, $, § (P ~< 0.05). 
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FIG. 6. (a) Glycosaminoglycan (GAG) weight or (b) dry 
weight of cartilage explants as a percentage of wet 
weight at 6 h, for selected treatments. GAG weight was 
assayed by the DMMB method [8] and dry weight was 
assayed by the acetone drying method [3], as described 
in the Methods. Group ][ and group II were 148 h and 
268 h controls, respectively. The remaining roups were 
assayed at 268h: group III was subjected to heavy 
(10 MPa) loading at 262 h, group IV was exposed to a 
high (1.0 mg/ml) drug dose at 100-120 h, and group V was 
subjected to the combined effects of a high dose at 
100-120 h and heavy loading at 262 h, as described in the 
Methods. In (a) and (b), the values for each group are 
mean ± S.D. (N= 6) expressed as a percentage of the 6 h 
wet weight determined on the harvest day. Differences in 
GAG or dry weight are indicated by *, t (P ~ 0.05). 
148 h or 268 h [Fig. 6(b)]. There was no detectable 
change in the 268 h dry content of explants which 
received a high dose at 100-120h. In contrast, 
the dry content of explants that received a 
high dose and later received heavy load at 262 h 
was decreased 17% (P < 0.05), relative to con- 
trols. Since the GAG content of untreated explants 
was only 12-13% of the total dry content, some of 
the lost dry content after high dose/heavy load 
must have been due to the loss of other matrix 
solids. 
Discuss ion  
Articular loading due to physical activity is 
always a factor after intra-articular corticosteroid 
therapy, but the exact levels of loading cannot be 
determined with precision. In the present study, 
drug dose and load intensity could be manipulated 
at will, and the effects of specific levels of these 
factors were isolated under controlled in vitro 
conditions. Several new observations uggesting 
important interactions between drug and load 
were made. On the positive side, drug-induced 
inhibition of PG synthesis was counteracted by a 
short period of loading 1 day after methylpred- 
nisolone exposure. On the negative side, the drug's 
anti-anabolic effects involved protein as well as PG 
synthesis after a week, and heavy load exacerbated 
the drug-induced loss of matrix solids. 
To our knowledge, the effects of in vitro 
corticosteroid exposure followed by loading have 
not been studied previously. The responses elicited 
from explanted cartilage may not be directly 
comparable to those occurring in the joints of 
living animals, but Fig. 3(b) suggested that 
methylprednisolone exposure could cause a dose- 
dependent inhibition of PG sulfation within 1-2 
days. This matched reports of reduced PG synthesis 
and content after corticosteroid injection into 
equine joints [1, 12]. At the high dose level, the 
drug's inhibitory effects were still in force a week 
later, and we can only conjecture that the explant 
metabolism ight have eventually recovered from 
the high dose, as has been observed in ponies at 3 
weeks after intra-articular injection [13]. There 
was a mild stimulation of PG synthesis a week after 
the low dose which did not quite reach significance. 
If confirmed, this might reflect a metabolic 
response to an earlier drop in PG synthesis and 
content, supporting the idea that PG synthesis is 
controlled by its concentration, as proposed by 
Sandy [27]. Low doses of one corticosteroid 
(triamcinolone hexacetonide) have been shown to 
slow the onset of surgically induced canine 
osteoarthrit is [6], and this was possibly due in part 
to a net stimulation of biosynthesis during 
recovery from low dose exposure. 
The ideal anti-arthrit ic drug would relieve pain 
and reduce synovial inflammation but it would also 
stimulate cartilage matrix synthesis. Corticos- 
teroids at clinical doses do not satisfy the last 
requirement, but they are useful because of their 
potent anti- inflammatory effects. Modern drugs 
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like methylprednisolone also have a substantial 
effect on water retention, as confirmed by our 
in vitro results. The observed increase then 
decrease in explant wet weight over the first 11 
days after harvest (Fig. 2) suggested a time-depen- 
dent injury response that affected extracellular 
water content. The low dose had no discernible 
effect on this swelling response, whereas the high 
dose reduced swelling a week after drug exposure, 
relative to controls (Fig. 2). Recognizing the 
limitations of our analogy between in vitro and 
in vivo swelling, this may support the idea that 
lower corticosteroid doses (high dose = 1/10 clinical 
dose) can still reduce joint swelling. 
Corticosteroid exposure had no effect on protein 
synthesis a day later, but the high dose had an 
anti-anabolic effect on protein synthesis a week 
later. There was also a severe loss of GAG a week 
after the high dose [group IV, Fig. 6(a)] and it is 
possible that this distorted some osmotic signal 
required to maintain normal protein synthesis. 
The net decrease in total protein synthesis did 
not exclude the possibility that synthesis of 
specific injury-response proteins was increased, yet 
masked by decreased synthesis of more plentiful 
proteins (for example, aggrecan core). 
Protein synthesis was stimulated by loading on 
the 6th day after harvest [Fig. 4(a)], but not on the 
l l th  day. Likewise, heavy load on the 6th day 
boosted PG metabolism back towards normal evels 
after drug exposure [Fig. 5(b)]. Other laboratories 
have reported anabolic effects of dynamic load on 
cartilage explants [28-31]. The drop-off in sensi- 
tivity to load between 6 and 11 days suggested that 
time in culture affected the explant's ability to 
modulate biosynthesis. It is therefore possible that 
a signal transduction mechanism which regulates 
normal cartilage metabolism deteriorated with 
time in defined culture. 
Heavy load alone did not cause a detectable GAG 
loss (contrast to [32]) but high dose exposure lead 
to a drop in GAG content after a week [Fig. 6(a)]. 
The drug may have reduced the size of the aggrecan 
monomer or of the PG aggregate [33] and this 
would facilitate GAG loss. However, our results 
suggested that heavy loading of drug-treated 
explants also promoted the loss of other matrix 
solids [Fig. 6(b)]. It seems reasonable to conjecture 
that drug-induced GAG loss might make cartilage 
more susceptible to matrix damage during loading. 
If so, this drugqoad interaction might explain the 
putatively destructive ffects of heavy exercise 
after corticosteroid injection. We hesitate to 
recommend changes in current medical practice 
on the basis of these in vitro results alone, but 
further study of the interaction between cortico- 
steroids and articular loading would be very 
worthwhile. 
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